BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• Business

  Biogen and Samsung Bioepis Agree to Settlement with AbbVie Allowing Commercialization of IMRALDI™ (Adalimumab Biosimilar) in Europe

  Biogen expects to launch IMRALDI in Europe on October 16, 2018

  April 5, 2018

   · 

  4 min read
• Biotech Bay

  Aradigm Announces the EMA Has Completed Its Validation of the MAA Submission

  The completion of the MAA validation is commensurate with the start date of the review procedure on March 29, 2018.

  April 5, 2018

   · 

  4 min read
• Drug Development

  DalCor Announces Expansion and Accelerated Enrollment of the dal-GenE Clinical Trial

  DalCor today announced that the company will increase enrollment in its ongoing Phase 3 clinical trial of dalcetrapib from 5000 to 6000 patients.

  April 5, 2018

   · 

  2 min read